https://www.selleckchem.com/B-Raf.html
ion with aging as well as the female gender. Reduced plasma miR-98 level is possibly considered a risk factor for coronary artery disease, and agomiR-98 prevents atherosclerosis and cellular injury by targeting lectin-like oxidized low-density lipoprotein receptor-1. Bevacizumab-combined chemotherapy is a new regimen for advanced/recurrent endometrial cancer. To evaluate the efficacy and safety of bevacizumab-combined chemotherapy in advanced/recurrent endometrial cancer. Systematic review and meta-analysis. Eligible studies were retrieved from Em